Healthcare -
Biotechnology - NASDAQ - US
$ 11.1
0.892 %
$ 161 M
Market Cap
0.11
P/E
INBX - REVENUE
Revenue INBX - Inhibrx Biosciences, Inc.
200 K
LAST VALUE
-69.70%
2 YEAR CAGR
-53.39%
5 YEAR CAGR
0.00%
10 YEAR CAGR